Jeffrey Dayno, MD

President and Chief Executive Officer, Harmony Biosciences, LLC

Professional Overview

Jeffrey Dayno, MD, is a seasoned pharmaceutical executive with over 35 years of experience in the industry. As the President and Chief Executive Officer of Harmony Biosciences, LLC, he leads the company's strategic vision and oversees its day-to-day operations, driving growth and innovation in the biopharmaceutical sector.

Experience Summary

Current Role

As the President and Chief Executive Officer of Harmony Biosciences, LLC, Dr. Dayno is responsible for setting the company's strategic direction, managing its operations, and fostering a culture of excellence. Since taking on this role in April 2023, he has been instrumental in shaping the company's product pipeline, strengthening its partnerships, and expanding its global reach.

Career Progression

Prior to his current role, Dr. Dayno served as the Interim Chief Executive Officer of Harmony Biosciences from January 2023 to April 2023. Before that, he held the position of Executive Vice President and Chief Medical Officer at Harmony Biosciences from 2017 to 2023, where he played a crucial role in the development and commercialization of the company's flagship product. Earlier in his career, Dr. Dayno held various leadership positions at other pharmaceutical companies, including Chief Medical Officer at Egalet Corporation, Vice President of Global Medical Affairs at ViroPharma Incorporated, and Chief Medical Officer at Labopharm.

Academic Background

Dr. Dayno earned his Doctor of Medicine (MD) degree from Temple University School of Medicine in 1988. He also holds a Bachelor of Arts (B.A.) in International/Global Studies from Trinity College-Hartford, where he graduated in 1979.

Areas of Expertise

Dr. Dayno's expertise spans a wide range of areas, including clinical development, regulatory affairs, medical affairs, and commercial strategy. He has a deep understanding of the pharmaceutical industry and a proven track record of successfully navigating complex regulatory environments and driving product commercialization.

Professional Impact

Throughout his career, Dr. Dayno has played a pivotal role in the development and commercialization of numerous pharmaceutical products. His leadership and strategic vision have been instrumental in advancing the industry and improving patient outcomes. At Harmony Biosciences, he continues to leverage his extensive experience to guide the company's growth and solidify its position as a leader in the biopharmaceutical sector.

Conclusion

With his exceptional leadership skills, extensive industry experience, and a deep commitment to innovation, Dr. Jeffrey Dayno is well-positioned to drive Harmony Biosciences' success and contribute to the advancement of the pharmaceutical industry as a whole.